CRISPR/Cas9 technology generated a G to T change a position 208 (c.208G>T) resulting in an aspartate to tyrosine substitution at amino acid 70 (p.Asp70Tyr). This is a pathogenic variant seen in patients with autosomal recessive nonsyndromic deafness 86.